Brown Advisory’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Brown Advisory’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-586,907	Closed	-$25.4M	–	1011
2015 Q3	$25.4M	Buy	586,907 +32,689	+6%	+$1.38M	0.09%	159
2015 Q2	$23.4M	Buy	554,218 +201,900	+57%	+$8.51M	0.08%	176
2015 Q1	$13.7M	Buy	352,318 +72,994	+26%	+$2.81M	0.04%	241
2014 Q4	$9.4M	Sell	279,324 -5,056	-2%	-$179K	0.03%	281
2014 Q3	$9.96M	Buy	284,380 +134,549	+90%	+$4.61M	0.03%	267
2014 Q2	$4.92M	Buy	+149,831	New	+$5.13M	0.02%	333

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Brown Advisory's WX Position: Q4 2015 in Review

Brown Advisory sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 586,907 shares — an estimated $25.4M sold.

Brown Advisory first reported a position in WX in Q2 2014 and held it in 6 quarters. The position peaked at $25.4M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Brown Advisory reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Brown Advisory sold 586,907 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $25.4M.
Brown Advisory first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2014 and held it in 6 quarters.
Brown Advisory's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $25.4M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Brown Advisory's 13F filing for Q4 2015, filed 8 Feb 2016.